XML 16 R6.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Millions
9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Operating activities    
Net earnings $ 12,589 $ 9,458
Noncash items:    
Depreciation and amortization 3,244 3,058
Deferred income taxes (1,019) (234)
Share-based compensation 795 831
Loss on sale of subsidiary and subsidiaries held for sale 139 8,331
Other, net 64 (610)
Net change in other operating items, net of effects from acquisitions and dispositions:    
Accounts receivable 65 685
Other assets (3,105) (2,988)
Medical costs payable 6,178 2,235
Accounts payable and other liabilities (417) 1,250
Unearned revenues 56 (181)
Cash flows from operating activities 18,589 21,835
Investing activities    
Purchases of investments (12,805) (19,951)
Sales of investments 7,945 15,065
Maturities of investments 6,517 6,738
Cash paid for acquisitions and other transactions, net of cash assumed (4,436) (11,674)
Purchases of property, equipment and capitalized software (2,674) (2,587)
Loans to care providers - cyberattack 0 (8,904)
Repayments of care provider loans - cyberattack 1,543 3,189
Other, net (2,164) (1,284)
Cash flows used for investing activities (6,074) (19,408)
Financing activities    
Common share repurchases (5,545) (4,028)
Cash dividends paid (5,914) (5,601)
Proceeds from common stock issuances 803 1,611
Repayments of long-term debt (2,000) (2,500)
Proceeds from (repayments of) short-term borrowings, net 1,469 (191)
Proceeds from issuance of long-term debt 2,969 17,811
Customer funds administered (1,792) (1,059)
Other, net (603) (1,213)
Cash flows (used for) from financing activities (10,613) 4,830
Effect of exchange rate changes on cash and cash equivalents 25 (30)
Increase in cash and cash equivalents, including cash within businesses held for sale 1,927 7,227
Less: net increase in cash within businesses held for sale (29) (254)
Net increase in cash and cash equivalents 1,898 6,973
Cash and cash equivalents, beginning of period 25,312 25,427
Cash and cash equivalents, end of period $ 27,210 $ 32,400